Your Location:
Home >
Browse articles >
Material Basis and Its Distribution in vivo of Qili Qiangxin Capsules Analyzed by UPLC-Q-Orbitrap-MS
Material Basis and Its Distribution
Enhanced Publicationin vivo of Qili Qiangxin Capsules Analyzed by UPLC-Q-Orbitrap-MS- Chinese Journal of Experimental Traditional Medical Formulae Vol. 31, Issue 5, Pages: 185-193(2025)
DOI: 10.13422/j.cnki.syfjx.20250263
Accepted:08 July 2024
Scan QR Code
Full Text(HTML)
Figs( 1 ) Tabs( 0 )
References
Publication Info
Metrics
551
Views
682
Downloads
5
CSCD
Alert me when the article has been cited
Submit
Tools
- BibTeXDownload
- EndnoteDownload
- RefMan Download
- NoteExpressDownload
- NoteFirstDownload
Related Articles
Qili Qiangxin Capsules Combined with Trimetazidine in Heart Failure Patients with Ischemic Cardiomyopathy
Prevention and Treatment of Heart Failure Combined with Type 2 Diabetes Mellitus by Integrated Traditional Chinese and Western Medicine: A Review
Mechanistic Study on Effect of Cycloastragenol in Improving Mitochondrial Function and Inhibiting Cardiac Remodeling via GPCR/cAMP/PKA/CREB Signaling Pathway
Clinical Application of Qili Qiangxin Capsules in Prevention and Treatment of Chronic Heart Failure: A Review
Traditional Chinese Medicine Intervention in Parkinson's Disease Based on Keap1/Nrf2/ARE Signaling Pathway: A Review
Related Author
CHEN Xiao-dong
ZHOU Jun
ZHANG Qilong
WU Wenjun
ZHA Xiaohu
CUI Ruyuan
WANG Aolong
WEI Jingjing
Related Institution
The First Affiliated Hospital of Henan University of Chinese Medicine
Collaborative Innovation Center of Prevention and Treatment of Major Diseases by Chinese and Western Medicine
Henan University of Chinese Medicine
School of Life Sciences, Beijing University of Chinese Medicine
Institute of Advanced Equipment, Tsinghua University


